The Brazilian state of Sao Paulo could roll out Sinovac's CoronaVac vaccine against SARS-CoV-2 even without approval from the federal health regulator Anvisa, as reported in NASDAQ.
The state's governor Joao Doria made the suggestion amid concern among some critics of President Jair Bolsonaro that the independence of Anvisa is under threat.
Doria said Sao Paulo could use the Sinovac vaccine based on approval from health regulators in other countries, adding "there is suspicion that Anvisa could suffer political interference."
He added the state would consider the vaccine appropriate for use if approved by authorities "in the US, in Europe and, above all, in Asia."
According to the news source, the Brazilian government's principal bet has been on a COVID-19 vaccine being developed by AstraZeneca, though federal health officials have also held talks with other vaccine developers, such as Johnson & Johnson and Pfizer.
To read more NewsPoints articles, click here.